With the blessing of their physicians and the drug company, patients would be able to sample drugs, products or devices that have passed the first phase of FDA clinical trials, Bonini explained, but are still far from being marketed and sold to the public.
"I think it just makes sense. It is a terrible situation people are facing and if we can perhaps save a life or two I think it will be well worth it," the Dover Republican said.
Delaware is among the 21 states, including New Jersey, poised to consider "Right to Try" legislation this year, according to the National Conference of State Legislatures. In 2014, five states, Arizona, Colorado, Louisiana, Michigan and Missouri, passed similar measures. Bonini worked with the Goldwater Institute, a right-wing advocacy group based in Arizona, on his bill.
